Product is First Non-Factor and Once-Weekly Treatment for Hemophilia B SILVER SPRING, Md., Oct. 11, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce […]
Aetna to support more Michigan residents eligible for both Medicare and Medicaid DETROIT, Oct. 11, 2024 /PRNewswire/ — Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for […]
Advisory Committee Voted 10 to 6 in Favor, Concluding that Elamipretide is Effective for the Treatment of Barth Syndrome Elamipretide NDA Received Priority Review with a PDUFA Action Date of January 29, 2025 If Approved, Elamipretide Would […]
UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB’s leadership in neuromuscular research Presentations showcase new data for UCB’s gMG treatments, including post hoc analyses […]
Koffee binding affinity is the latest addition to Kvantify’s computational drug discovery platform, helping the pharmaceutical and biotech industries design new drugs with an unmatched combination of speed and precision. COPENHAGEN, Denmark, Oct. 11, 2024 […]
